VYBION
Vybion is a development stage company with platform technology for the development of a new drug class called Intrabodies. Their lead candidate for Huntington's and Azheimer's diseases is INT41 an scFv fragment that can alter gain of toxic function in Huntington's disease and block Fyn kinase binding to Tau in Alzheimer's disease. The Company operates virtually out of Monterey, CA and is focused on completing an IND enabling package for INT41.
VYBION
Social Links:
Industry:
Biotechnology
Address:
Monterey, California, United States
Country:
United States
Website Url:
http://www.vybion.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
SSL By Default Apache AJAX Libraries API Google Apps For Business PHP Sectigo SSL Sectigo Domain SSL Digital Ocean Network Solutions DNS
Similar Organizations
Acqua Innovations
Acqua Innovations, Inc. is a pre-revenue, development stage company.
Innovive Pharmaceuticals
Innovive Pharmaceuticals is a development stage company.
Microlin Bio
Microlin Bio, Inc., a development stage biopharmaceutical company.
Rindex Medical
Rindex Medical is a developmental-stage company.
Official Site Inspections
http://www.vybion.com
- Host name: one.cyrus.love
- IP address: 167.71.250.69
- Location: Clifton United States
- Latitude: 40.8364
- Longitude: -74.1403
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07014
More informations about "Vybion"
VYBION : Antibody Innovations
Feb 20, 2017 · Vybion is the leading developer of Intrabodies for neurodegenerative diseases, leveraging the safety and effectiveness of antibody technologies to address unmet medical …See details»
Vybion - Crunchbase Company Profile & Funding
Vybion is a development stage company with platform technology for the development of a new drug class called Intrabodies. Their lead candidate for Huntington's and Azheimer's diseases …See details»
Vybion Company Profile 2024: Valuation, Funding & Investors
Provider of a patented drug discovery services intended to offer proteins for diagnostics and therapeutic drugs.See details»
Vybion, Inc. - LinkedIn
Vybion, Inc. | 265 followers on LinkedIn. The Vectorized Intrabody Company | Vybion developed a novel vectorized intrabody (INT41) for Huntington’s disease, a devastating inherited orphan disease...See details»
VYBION : Antibody Innovations
Vybion has pioneered vectorized Intrabodies, the delivery of functional antibody fragments in the scFv format to cells using Adeno associated virus (AAV). The Company has Orphan Drug …See details»
Antibody Innovations - VYBION
About Vybion. Management; Board of Directors; Pipeline; Technology; Partnerships and Licensing; Latest News; Home | About Us | Pipeline | ProCode | Partnerships and ...See details»
Vybion - Products, Competitors, Financials, Employees, …
Vybion is a biotechnology company focused on the development of Intrabodies for neurodegenerative diseases. The company's main offerings include therapeutic Intrabodies …See details»
Vybion, Inc. Company Profile | Monterey, CA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Vybion, Inc. of Monterey, CA. Get the latest business insights from Dun & Bradstreet.See details»
Vybion Company Profile - Office Locations, Competitors, Revenue …
Vybion is a company that develops intrabodies for neurodegenerative diseases. Its intrabodies are the scFv fragments that target and change intracellular events like the protein aggregation, …See details»
Vybion, Inc - BIO International Convention | BIO
Jun 6, 2023 · Vybion is a virtual gene therapy company with Orphan Designation from the FDA for a Huntington's Disease therapy. We have pioneered the vectorized antibody space and …See details»
Vybion Profile - Medical XPRT
Vybion has pioneered vectorized Intrabodies, the delivery of functional antibody fragments in the scFv format to cells using Adeno associated virus (AAV). The Company has Orphan Drug …See details»
VYBION, INC. - VentureRadar
Vybion is the leading developer of Intrabodies for neurodegenerative diseases, leveraging the safety and effectiveness of antibody technologies to address unmet medical needs.See details»
A look into Vybion - Upstate Venture Connect - UVC
By: Maureen Newman, UVC Biomedical Engineering Community Connector With a strong history in investigational new drug (IND) enabling processes, Lee Henderson, PhD, …See details»
Vybion | Scientist.com
Vybion provides gene identification and cloning, purification, bioassay, recombinant protein, viral and antibody services. If your organization has a Scientist.com marketplace, you can log in …See details»
Antibody Innovations - VYBION
Lee A. Henderson, Ph.D., President/CEO and Founder. Dr. Henderson has developed IND enabling processes for drugs in multiple therapeutic areas including first in human IND …See details»
FDA Orphan Designation Moves Vybion's Huntington’s Therapy …
Dec 6, 2018 · Vybion is developing a new treatment class called Intrabodies — specialized antibodies meant to block the toxic function of aggregating proteins — for several inherited …See details»
Antibody Innovations - VYBION
Apr 3, 2018 · About Vybion, Inc. Vybion is a development stage Company with proprietary technologies for Intrabody development currently pursuing strategies to treat …See details»
Vybio - Crunchbase Company Profile & Funding
Vybio focuses on the research and development of new drugs for oncology and hepatitis B. The core members of the team have 30 years of experience in tumor and hepatitis B drug research …See details»
Research programme: respiratory virus inhibitor - Vybion
Vybion (formerly Viral Therapeutics), is developing a recombinant human protein [Virusorb] for the prophylaxis and treatment of acute respiratory virusesSee details»
VYBION : Antibody Innovations
Vybion Drug Pipeline. INT41 has received Orphan Drug Designation from the FDA for Huntington’s disease.See details»